References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
GruelandGlaser(1992)Theputative5-HT1AreceptorantagonistsNAN-190andBMY7378arepartialagonistsintheratdorsalraphenucleusinvitro.Eur.J.Pharmacol.211211PMID:1535319
Piasciketal(1995)Thespecificcontributionofthenovelalpha-1Dadrenoceptortothecontractionofvascularsmoothmuscle.J.Pharmacol.Exp.Ther.2751583PMID:8531132
Sharpetal(1990)Furtherinvestigationoftheinvivopharmacologicalpropertiesoftheputative5-HT1Aantagonist,BMY7378.Eur.J.Pharmacol.176331PMID:1970304
YangandEndoh(1997)Pharmacologicalevidenceforβ1D-adrenoceptorsintherabbitventricularmyocardium:analysiswithBMY7378.Br.J.Pharmacol1221541PMID:9422797
Keywords:BMY7378dihydrochloride,supplier,Selective,α1D-adrenoceptor,alpha1D-adrenoceptor,a1d-adrenoceptor,α1d-adrenergic,alpha1d-adrenergic,a1d-adrenergic,antagonist,5-HT1A,partial,agonists,Receptors,SEROtonin,BMY7378,dihydrochloride,Adrenergic,Alpha-1,Receptors,5-HT1A,Receptors,Adrenergic,Alpha-1,Receptors,TocrisBioscience